Insufficient scRNA-seq data for expression of APELA at single-cell level.
Insufficient scRNA-seq data for expression of APELA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 89% | 122.25 | 218 / 245 | 85% | 5.75 | 425 / 502 |
breast | 42% | 23.56 | 194 / 459 | 35% | 1.15 | 390 / 1118 |
skin | 54% | 25.79 | 983 / 1809 | 3% | 0.08 | 16 / 472 |
kidney | 39% | 30.38 | 35 / 89 | 9% | 0.42 | 82 / 901 |
lung | 5% | 0.85 | 30 / 578 | 25% | 0.96 | 288 / 1155 |
pancreas | 0% | 0.03 | 1 / 328 | 29% | 1.06 | 52 / 178 |
ovary | 4% | 0.61 | 8 / 180 | 23% | 0.99 | 99 / 430 |
intestine | 11% | 1.71 | 107 / 966 | 9% | 0.18 | 49 / 527 |
peripheral blood | 18% | 92.26 | 170 / 929 | 0% | 0 | 0 / 0 |
thymus | 6% | 1.04 | 37 / 653 | 9% | 0.76 | 56 / 605 |
bladder | 0% | 0 | 0 / 21 | 15% | 0.40 | 75 / 504 |
uterus | 1% | 0.20 | 2 / 170 | 12% | 0.51 | 57 / 459 |
esophagus | 7% | 1.12 | 104 / 1445 | 5% | 0.13 | 10 / 183 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.19 | 5 / 45 |
stomach | 0% | 0 | 0 / 359 | 9% | 0.19 | 27 / 286 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.18 | 1 / 29 |
liver | 0% | 0 | 0 / 226 | 2% | 0.11 | 8 / 406 |
brain | 1% | 0.13 | 19 / 2642 | 1% | 0.08 | 7 / 705 |
blood vessel | 2% | 1.27 | 21 / 1335 | 0% | 0 | 0 / 0 |
adipose | 1% | 0.35 | 11 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.03 | 1 / 258 | 0% | 0.02 | 1 / 230 |
heart | 1% | 0.08 | 6 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.13 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0007507 | Biological process | heart development |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_1901165 | Biological process | positive regulation of trophoblast cell migration |
GO_0001570 | Biological process | vasculogenesis |
GO_0060976 | Biological process | coronary vasculature development |
GO_1904022 | Biological process | positive regulation of G protein-coupled receptor internalization |
GO_0007492 | Biological process | endoderm development |
GO_0060674 | Biological process | placenta blood vessel development |
GO_0007512 | Biological process | adult heart development |
GO_0035050 | Biological process | embryonic heart tube development |
GO_0090133 | Biological process | mesendoderm migration |
GO_0045823 | Biological process | positive regulation of heart contraction |
GO_0090134 | Biological process | cell migration involved in mesendoderm migration |
GO_0007509 | Biological process | mesoderm migration involved in gastrulation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1903589 | Biological process | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO_0060183 | Biological process | apelin receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
GO_0031704 | Molecular function | apelin receptor binding |
Gene name | APELA |
Protein name | Apelin receptor early endogenous ligand (Protein Elabela) (ELA) (Protein Toddler) |
Synonyms | ELA TDL |
Description | FUNCTION: Endogenous ligand for the apelin receptor (APLNR) . Hormone required for mesendodermal differentiation, blood vessels formation and heart morphogenesis during early development and for adult cardiovascular homeostasis . Drives internalization of APLNR. Acts as a motogen by promoting mesendodermal cell migration during gastrulation by binding and activating APLNR. Acts as an early embryonic regulator of cellular movement with a role in migration and development of cardiac progenitor cells. May act as a chemoattractant for the activation of angioblast migration toward the embryonic midline, i.e. the position of the future vessel formation, during vasculogenesis. Positively regulates sinus venosus (SV)-derived endothelial cells migration into the developing heart to promote coronary blood vessel sprouting. Plays a role in placental vascular development; promotes placental trophoblast invasion and spiral artery remodeling in the uterus. Involved in the regulation of maternal cardiovascular homeostasis to prevent gestational hypertension and for potent cardioprotective functions during heart failure. Mediates myocardial contractility in an ERK1/2-dependent manner (By similarity). . |
Accessions | ENST00000510062.5 ENST00000507152.6 ENST00000515275.1 P0DMC3 |